The kit allows the identification of 5 mutations in DPYD gene associated to clinically relevant adverse event to the chemioterapic agent
Mutations:
c.1905+1G>A
c.1679T>G
c.2846A>T
c.1129–5923C>G (variante in linkage disequilibrium con c.1236G>A)
c.2194G>A